Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Studies Presented At Symposium Examine Efficacy Of Breast Cancer Treatments
http://www.medicalnewstoday.com/articles/133155.php
The following summarizes news coverage of two studies presented last week at the <A href="http://www.sabcs.org/" target=_new>San Antonio Breast Cancer Symposium</A> in Texas. <BR /><BR />~ Zometa: Women with breast cancer who take <A href="http://www.
Evolution, Instability Of Cancer Shown By Breast Cancer Genome
http://www.medicalnewstoday.com/articles/133119.php
A newly published genome sequence of a breast cancer cell line reveals a heavily rearranged genetic blueprint involving breaks and fusions of genes and a broken DNA repair machinery, said researchers at Baylor College of Medicine in a report that appears online in the journal <i>Genome Research.
Preventing Metastasis To 'Stop Cancer From Killing People'
http://www.medicalnewstoday.com/articles/133110.php
Metastasis is the ability of cancer cells to spread from a primary site, to form tumours at distant sites. It is a complex process in which cell motility and invasion play a fundamental role.
Using Light To Detect Cancer Withing Second - Breast Surgeon Wins Prestigious Healthcare Innovation Award, England
http://www.medicalnewstoday.com/articles/133100.php
A Royal Free breast surgeon has won a prestigious healthcare innovation award with a state-of-the-art technique that uses light to detect cancer within seconds. Mr Mohammed Keshtgar, consultant surgical oncologist, has won a 2008 Medical Futures Cancer Innovation Award and been shortlisted in the category of overall winner of the award with his pioneering work in optical biopsy.
ABRAXANE In Combination With Gemcitabine And Epirubicin Evaluated As Neoadjuvant Treatment For Patients With Locally Advanced Breast Cancer
http://www.medicalnewstoday.com/articles/133065.php
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of preliminary results from a single-arm, open-label, Phase II clinical trial evaluating ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin- bound) in combination with gemcitabine and epirubicin for the treatment of patients with locally advanced breast cancer (neoadjuvant treatment).
Cancer Prevention Study Reveals Encouraging News For Exemestane
http://www.medicalnewstoday.com/articles/133060.php
An interim analysis of a breast cancer prevention study using exemestane (Aromasin®) finds an "acceptable" level of bone loss.The ongoing phase II study details reported by Jennifer Eng-Wong, MD, a breast cancer specialist at Georgetown's Lombardi Comprehensive Cancer Center at the San Antonio Breast Cancer Symposium, examines the use of exemestane in postmenopausal women who are at an increased risk of developing breast cancer based on commonly used risk assessment measures.
Potential Links Discovered Between Breast Density And Breast Cancer Risk
http://www.medicalnewstoday.com/articles/133058.php
Having dense breasts - areas that show up light on a mammogram - is strongly associated with increased breast cancer risk, but "why" remains to be answered. Now, by examining dense and non-dense tissue taken from the breasts of healthy volunteers, researchers from Mayo Clinic have found several potential links.
In Young Women With Benign Breast Disease, Breast Cancer Risk Varies According To Mayo Clinic Researchers
http://www.medicalnewstoday.com/articles/133057.php
A type of benign breast disease (BBD) known as atypical hyperplasia substantially increases a young woman's risk of developing breast cancer, even if there is no history of breast cancer in her family, say researchers at Mayo Clinic.
Tau Protein Expression Predicts Breast Cancer Survival -- Though Not As Expected
http://www.medicalnewstoday.com/articles/133056.php
Expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy, according to research led by The University of Texas M.
----------------------------------------------
** CANCER / ONCOLOGY News **
Unique U-M Surgery Creates Fully Usable Tongue Following Tongue Cancer
http://www.medicalnewstoday.com/articles/133139.php
The night before her surgery for tongue cancer, 30-year-old Lisa Bourdon-Krause realized she might never be able to speak to her toddler son again. So she sat up half the night recording messages to him: "Hi, how was your day?," "You're so handsome," "You have a stinky butt.
American Academy Of Dermatology Issues Statement On FDA Report To Congress About Labeling Information On Indoor Tanning Devices
http://www.medicalnewstoday.com/articles/133138.php
The American Academy of Dermatology (Academy) issued a statement in response to the Food and Drug Administration's Report to Congress about labeling information on the relationship between the use of indoor tanning devices and development of skin cancer or other skin damage.
Cylene Pharmaceuticals Initiates Phase II Clinical Trial Of Quarfloxin (CX-3543) In Patients With Carcinoid/Neuroendocrine Tumors
http://www.medicalnewstoday.com/articles/133135.php
Cylene Pharmaceuticals announced the initiation of a Phase II clinical trial of quarfloxin (CX-3543) in patients with carcinoid/neuroendocrine tumors (C/NET), which are malignant cancers arising from neural crest cells.
Shared Survival Mechanism Explains Why 'Good' Nerve Cells Last And 'Bad' Cancer Cells Flourish
http://www.medicalnewstoday.com/articles/133120.php
Cancer cells and nervous system neurons may not look or act alike, but both use strikingly similar ways to survive, according to new research from the University of North Carolina at Chapel Hill School of Medicine.
Possible Therapeutic Target For Pancreatic Cancer
http://www.medicalnewstoday.com/articles/133108.php
A possible new therapeutic target for pancreatic cancer, the most lethal form of human cancer, has been identified in the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," according to researchers at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec.
Using Light To Detect Cancer Withing Second - Breast Surgeon Wins Prestigious Healthcare Innovation Award, England
http://www.medicalnewstoday.com/articles/133100.php
A Royal Free breast surgeon has won a prestigious healthcare innovation award with a state-of-the-art technique that uses light to detect cancer within seconds. Mr Mohammed Keshtgar, consultant surgical oncologist, has won a 2008 Medical Futures Cancer Innovation Award and been shortlisted in the category of overall winner of the award with his pioneering work in optical biopsy.
ABRAXANE In Combination With Gemcitabine And Epirubicin Evaluated As Neoadjuvant Treatment For Patients With Locally Advanced Breast Cancer
http://www.medicalnewstoday.com/articles/133065.php
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of preliminary results from a single-arm, open-label, Phase II clinical trial evaluating ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin- bound) in combination with gemcitabine and epirubicin for the treatment of patients with locally advanced breast cancer (neoadjuvant treatment).
Tau Protein Expression Predicts Breast Cancer Survival -- Though Not As Expected
http://www.medicalnewstoday.com/articles/133056.php
Expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy, according to research led by The University of Texas M.
Clatterbridge Centre For Oncology Ranked As One Of The Best Healthcare Organisations To Work For In The UK
http://www.medicalnewstoday.com/articles/132953.php
Clatterbridge Centre for Oncology is one of the Top 100 healthcare organisations to work for in the UK according to a survey by the <i>Health Service Journal</i>. The survey asked employees at the Centre a range of questions and the Centre has been included in the Top 100 list! The final results will be announced in March 2009, when the Centre will find out where they came in the top 100.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Colon Cancer Mortality Gap Between Blacks, Whites Widening, Report Finds
http://www.medicalnewstoday.com/articles/133179.php
The gap in colon cancer mortality between blacks and whites has been widening over the last two decades, in part because of blacks' lower screening rates and poorer access to care, according to an <a href="http://www.
Aspirin Not Effective In Preventing Lynch Syndrome
http://www.medicalnewstoday.com/articles/133144.php
Aspirin, recommended as a preventive approach for patients at risk of hereditary colorectal cancer, does not provide protection against Lynch syndrome, the most common form of hereditary colorectal cancer, according a study published in the Dec.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
USA's Largest Ever Prostate Cancer Screening Programme Shows High Compliance And Consistent Results
http://www.medicalnewstoday.com/articles/133095.php
Just under five per cent of the men who took part in the prostate cancer element of the USA's largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes, according to research published in the December issue of the UK-based urology journal <i>BJU International.
Low Income Men Diagnosed More Often With Advanced Prostate Cancer, The Journal Of Urology
http://www.medicalnewstoday.com/articles/133068.php
Coincident with the widespread adoption of PSA screening, the proportion of American men diagnosed with organ-confined, low risk prostate cancer has increased significantly during the last two decades.
Combining Radiotherapy With Hormone Treatment Halves Prostate Cancer Mortality
http://www.medicalnewstoday.com/articles/133067.php
In patients with locally advanced or high-risk prostate cancer, combining prostate radiotherapy with the conventional endocrine (hormone) treatment halves mortality. Thus endocrine treatment plus radiotherapy should be the new standard.
Centers Nationwide Participating In Clinical Trial To Determine Effectiveness Of High-Intensity Focused Ultrasound Procedure For Prostate Cancer
http://www.medicalnewstoday.com/articles/133050.php
EDAP Technomed, Inc. announces the launch of a phase II/III clinical trial evaluating the effectiveness of a non-invasive medical device designed to target and treat prostate cancer with high-intensity focused ultrasound (HIFU).
Study Finds That Low-Income Men Are More Likely To Be Diagnosed With Advanced Prostate Cancers
http://www.medicalnewstoday.com/articles/133048.php
Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment